Telithromycin
Back to searchMolecule Structure
Scientific Name
Telithromycin
Description of the Drug
Telithromycin is an ketolide used to treat community acquired pneumonia of mild to moderate severity.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00976
http://www.drugbank.ca/drugs/DB00976
Brand Name(s)
Ketek
Company Owner(s)
Sanofi Aventis Us Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2363135 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL5100 | |
DrugBank | DB00976 | |
PubChem: Thomson Pharma | 14913885 | 14767066 |
PubChem | 3002190 | |
Nikkaji | J982.785D | |
PDBe | TEL | |
BindingDB | 50378137 | |
EPA CompTox Dashboard | DTXSID3046455 | |
DrugCentral | 2581 | |
rxnorm | KETEK | TELITHROMYCIN |
PubChem: Drugs of the Future | 12015022 | |
ZINC | ZINC000009574770 |